找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Immunotherapy; Aung Naing,Joud Hajjar Book 2021Latest edition The Editor(s) (if applicable) and The Author(s), under exclusive license to

[復(fù)制鏈接]
樓主: 選民
21#
發(fā)表于 2025-3-25 04:16:48 | 只看該作者
22#
發(fā)表于 2025-3-25 11:25:21 | 只看該作者
Abdulrazzak Zarifa,Juan Lopez-Mattei,Nicolas L. Palaskas,Cezar Iliescu,Jean-Bernard Durand,Peter Y. tinued to be the case despite recent advances in the treatment of acute events, which have proven to decrease disability and improve outcomes. Over recent years, there has been significant growth in the field of acute stroke care and stroke systems of care. This includes improvements in the manageme
23#
發(fā)表于 2025-3-25 14:22:34 | 只看該作者
24#
發(fā)表于 2025-3-25 17:57:31 | 只看該作者
25#
發(fā)表于 2025-3-25 23:54:47 | 只看該作者
Immunotherapy for Melanoma,n, we provide an overview of the results of recent advances in the adjuvant setting for patients with resected stage III and stage IV melanoma, as well as in patients with melanoma brain metastases. Finally, we provide a brief overview of the current research efforts in the field of immuno-oncology for melanoma.
26#
發(fā)表于 2025-3-26 00:16:11 | 只看該作者
27#
發(fā)表于 2025-3-26 07:50:37 | 只看該作者
Immune Checkpoint Inhibitor (ICI)-Related Cardiotoxicity,toxicities related to immunotherapy are reportedly rare, they can be severe and associated with life-threatening conditions such as fulminant myocarditis, hemodynamic instability, and cardiac arrest. We will review the most commonly reported cardiovascular toxicities associated with ICIs and their management.
28#
發(fā)表于 2025-3-26 08:36:35 | 只看該作者
29#
發(fā)表于 2025-3-26 13:16:06 | 只看該作者
Resistance to Immunotherapy: Mechanisms and Means for Overcoming,rucial to understand the pathophysiology of the tumor-immune system interplay and the mechanisms of immune escape in order to circumvent primary and acquired resistance. Here we provide an outline of the most well-defined mechanisms of resistance and shed light on ongoing efforts to reinvigorate immunoreactivity.
30#
發(fā)表于 2025-3-26 16:49:46 | 只看該作者
Renal Toxicity, autoimmune disease with a focus on renal cell cancer in setting of chronic kidney disease (CKD). Transplant rejection in setting of CPI use has been further evaluated with single-center and multicenter retrospective studies, and available data will be presented in this chapter.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 09:24
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
犍为县| 安陆市| 珠海市| 五河县| 湘乡市| 阿克陶县| 英超| 碌曲县| 西华县| 白朗县| 百色市| 砀山县| 鄂托克前旗| 黔东| 兴安县| 石狮市| 横山县| 桦川县| 昌乐县| 噶尔县| 沙雅县| 大兴区| 黄浦区| 信阳市| 漾濞| 和田县| 达拉特旗| 长宁县| 怀柔区| 科技| 大方县| 西藏| 镶黄旗| 湖口县| 珠海市| 浙江省| 抚顺县| 呼伦贝尔市| 台前县| 炉霍县| 郓城县|